RONA THERAPEUTICS ENTERS INTO GLOBAL LICENSE AGREEMENT WITH ROCHE FOR ALK7-TARGETING RNAI THERAPY FOR OBESITY AND METABOLIC DISEASES

Reuters · 2d ago

Please log in to view news